Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

Antiplatelet therapy is widely used with proven benefit for the prevention of further ischemic cardiac complications in patients with acute coronary syndrome. Treatment guidelines for acute coronary syndrome and percutaneous coronary intervention now recommend the use of oral antiplatelet agents inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Estella M, Knezevich, Jon T, Teply, Robyn M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640601/
https://www.ncbi.nlm.nih.gov/pubmed/23650452
http://dx.doi.org/10.2147/CPAA.S41859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640601/
https://www.ncbi.nlm.nih.gov/pubmed/23650452
http://dx.doi.org/10.2147/CPAA.S41859

Ejemplares similares